← Back to Clinical Trials
Recruiting NCT07245355

NCT07245355 Contribution of Recreational Exercises to Balance and Muscle Strength in Osteoporosis Risk

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07245355
Status Recruiting
Phase
Sponsor Suleyman Demirel University
Condition Osteoporosis (Senile)
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-05-01
Primary Completion 2026-05-01

Eligibility & Interventions

Sex Female only
Min Age 40 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Experimental Group 1Experimental Group 2Experimental Group 3

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-05-01 with a primary completion date of 2026-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the effects of recreational exercises such as Pilates, swimming and walking on muscle strength and balance in women at risk of osteoporosis. Study hypotheses: H1: Pilates exercises will be more effective than walking exercises in improving muscle strength among women at risk of osteoporosis. H2: Swimming exercises will be more effective than walking exercises in improving muscle strength among women at risk of osteoporosis. H3: Pilates exercises will be more effective than walking exercises in improving balance among women at risk of osteoporosis. H4: Swimming exercises will be more effective than walking exercises in improving balance among women at risk of osteoporosis. H5: Pilates and swimming exercises will have similar effects on improving muscle strength and balance among women at risk of osteoporosis.

Eligibility Criteria

Inclusion Criteria: 1. Having a sedentary lifestyle (not having exercised regularly in the past 6 months), 2. No musculoskeletal or neurological conditions that would prevent participation, 3. Voluntarily agreeing to participate in the study. Exclusion Criteria: 1. Use of medications affecting bone metabolism (e.g., bisphosphonates, corticosteroids), 2. History of fracture within the past 6 months, 3. Uncontrolled cardiovascular or metabolic diseases.

Contact & Investigator

Central Contact

NUR ALP, MSc

✉ nuralp@sdu.edu.tr

📞 +905339738832

Principal Investigator

HULUSİ ALP, Professor

STUDY DIRECTOR

Suleyman Demirel University

Frequently Asked Questions

Who can join the NCT07245355 clinical trial?

This trial is open to female participants only, aged 40 Years or older, up to 60 Years, studying Osteoporosis (Senile). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07245355 currently recruiting?

Yes, NCT07245355 is actively recruiting participants. Contact the research team at nuralp@sdu.edu.tr for enrollment information.

Where is the NCT07245355 trial being conducted?

This trial is being conducted at Isparta, Turkey (Türkiye).

Who is sponsoring the NCT07245355 clinical trial?

NCT07245355 is sponsored by Suleyman Demirel University. The principal investigator is HULUSİ ALP, Professor at Suleyman Demirel University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology